Source link : https://www.newshealth.biz/health-news/how-will-it-shape-clinical-practice/
A position statement released by the American Headache Society (AHS) earlier this year recommended adding calcitonin gene-related peptide (CGRP)–targeting medications to the list of first-line therapies for migraine prevention. The guidance replaces recommendations published in 2021 that advised clinicians consider CGRP therapy only after patients fail at least two classes of oral migraine prevention medications […]
Author : News Health
Publish date : 2024-06-20 07:22:05
Copyright for syndicated content belongs to the linked Source.
Categories